Evidence map›Paper›PMID 34091982›Full record

SynthesisReviews in medical virology2022

Role of red blood cell distribution width, as a prognostic indicator in COVID-19: A systematic review and meta-analysis.

Soumya Sarkar, Sundara Kannan, Puneet Khanna, Akhil Kant Singh

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Reviews in medical virology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Soumya SarkarDepartment of Anaesthesia, Pain Medicine & Critical Care, AIIMS, New Delhi, India.ORCID https://orcid.org/0000-0003-0497-9909
Sundara KannanDepartment of Anaesthesia, Pain Medicine & Critical Care, AIIMS, New Delhi, India.
Puneet KhannaDepartment of Anaesthesia, Pain Medicine & Critical Care, AIIMS, New Delhi, India.ORCID https://orcid.org/0000-0002-9243-9963
Akhil Kant SinghDepartment of Anaesthesia, Pain Medicine & Critical Care, AIIMS, New Delhi, India.ORCID https://orcid.org/0000-0002-6662-9819

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The red blood cell distribution width (RDW), an indicator of anisocytosis has emerged as a potential tool for risk stratification of critically ill patients with sepsis. Prognostic predictors are of paramount interest for prompt intervention and optimal utilization of the healthcare system in this ongoing context of the Coronavirus Disease 2019 (COVID-19) pandemic. The current systematic review and meta-analysis aims to explore the utility of RDW in the prognosis of COVID-19 patients. A comprehensive screening of electronic databases was performed up to 30th April 2021 after enrolling in PROSPERO (CRD42020206685). Observational studies or interventional studies, evaluating the impact of RDW in COVID-19 outcomes (mortality and severity) are included in this meta-analysis.Our search retrieved 25 studies, with a total of 18,392 and 3,446 COVID-19 patients for mortality and disease severity outcomes. Deceased and critically ill patients had higher RDW levels on admission in comparison to survivors and non-severe patients (SMD = 0.46; 95%CI 0.31-0.71; I

Indexed as

COVID-19Erythrocyte IndicesErythrocytesHumansObservational Studies as TopicPrognosisSARS-CoV-2Coronavirus Disease 2019red blood cell distribution widthSevere Acute Respiratory Syndrome Coronavirus-2

Identifiers

PMID34091982
PMCPMC8209859

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.